JNJ: On track to start #COVID19vaccine Phase 1 #clinicaltrials in early September in the US. This could allow vaccine availability for emergency use authorization by 2021. 

https://t.co/Bf1vWWSLCe

$JNJ $MRK $PFE $SNY #Earnings #COVID19 #stocknews